KPRX
Kiora Pharmaceuticals Inc
$2.55
+0.00 (+0.00%)
At close · Jul 7
Market Cap
$11.26M
Shares
4,431,940
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Praveen Tyle, Ph.D. | Class II Director | Appointed | 2026-06-11 |
| Aron Shapiro | Class II Director | Appointed | 2026-06-11 |
| Lisa Walters-Hoffert | Class II Director | Appointed | 2026-06-11 |